ASH 2016: Cutaneous T-Cell Lymphoma Treatment News

At the 2016 American Society of Hematology (ASH) meeting in San Diego, Dr. Steven Horwitz of Memorial Sloan Kettering Cancer Center explores new and emerging treatments for cutaneous T-cell lymphoma, including the results of the ALCANZA Trial.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo